Quinolisin

喹诺利辛

Report date: 2024/04/22 20:00:10
NME

Base Information

Drug NameQuinolisin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Kanion Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A